Asymchem to Repurchase and Cancel 33,000 Restricted A Shares After Staff Resignations

The latest announcement is out from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ).

Asymchem Laboratories (Tianjin) Co., Ltd. has approved the repurchase and cancellation of 33,000 restricted A shares previously granted under its 2025 A Share restricted share incentive scheme to eight participants who have resigned from the company. Following this move, the number of incentive participants and total restricted shares under both the initial and reserved grants will be slightly reduced, and the company’s A share capital will decrease marginally from 333,040,460 to 333,007,460 shares, with total share capital falling to 360,560,720 shares. The repurchase will be funded entirely from internal resources at adjusted prices of RMB36.42 and RMB53.24 per share for the initial and reserved grants, respectively, and management expects no material impact on the company’s financial position, operating results or the continued implementation of the 2025 A Share Scheme, signaling that the change is largely administrative in nature for shareholders and other stakeholders.

The most recent analyst rating on (HK:6821) stock is a Buy with a HK$98.40 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.

More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H

Asymchem Laboratories (Tianjin) Co., Ltd. is a China-based pharmaceutical services company specializing in contract development and manufacturing services (CDMO) for drug research and production. Listed in Hong Kong with both A shares and H shares, the company focuses on providing integrated chemistry and manufacturing solutions to global pharmaceutical and biotech clients.

Average Trading Volume: 357,799

Technical Sentiment Signal: Sell

Current Market Cap: HK$35.6B

Learn more about 6821 stock on TipRanks’ Stock Analysis page.